Article
Massimo Di Maio, Francesco Perrone, Pierfranco Conte
Season 1, Episode 9: Career Insights From a CEO with Mark Erlander
We are thrilled to welcome Mark Erlander PHD, CEO of Cardiff Oncology, shares his journey from a PhD in neuroscience to leading an oncology company. He discusses the calculated risks he took throughout his career and the importance of following your passion. Erlander emphasizes the need for leaders to be motivated and to create a team that is excited to work together. "Create a motivated team by fostering trust, respect, and providing resources" He tells up and comers to do something they are truly excited about, but also be be opportunistic and willing to take calculated risks. We jump in to discussions on the future of cancer treatments, including targeted therapies and personalized medicine.
Key Points:
❇Follow your passion and do something you are truly excited about
🤗Create a motivated team by fostering trust, respect, and providing resources
📈Be opportunistic and willing to take calculated risks
❌Never settle for something that is less than what you want to achieve
💊The future of cancer treatments includes targeted therapies and personalized medicine
Related Topics
You May Also Like
Massimo Di Maio, Francesco Perrone, Pierfranco Conte
Article
E.M. Ray, L.A. Carey, K.E. Reeder-Hayes
Leveraging existing data to contextualize phase II clinical trial findings in oncology
Podcast
The Oncology Nursing Podcast
Patient Education for Next-Generation Sequencing to Guide Cancer Therapy
Article
Kelvin Chan, Seungree Nam, Bill Evans, Claire de Oliveira Alexandra Chambers, Scott Gavura, Jeffrey Hoch, Rebecca E Mercer, Wei Fang Dai, Jaclyn Beca, Mina Tadrous, Wanrudee Isaranuwatchai
Developing a framework to incorporate real-world evidence in cancer drug funding decisions: the Canadian Real-world Evidence for Value of Cancer Drugs (CanREValue) collaboration
Article
Doreen A. Ezeife MD, Francois Dionne PhD, Aline Fusco Fares MD, Ellen Laura Rose Cusano MD, Rouhi Fazelzad BSc, MISt, Wenzie Ng BSc, MPharm, RPh, Don Husereau BSc Pharm, MSc, Farzad Ali BPharm, MSc, Christina Sit MSc, Barry Stein B.Com BCL, LLB, Jennifer
Value assessment of oncology drugs using a weighted criterion-based approach
Article
Haiqing Isaac Dai, Yulia Vugmeyster, Naveen Mangal